These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypes. Safaie P; Ham M; Kuang P; Mehta AS; Wang M; Cheifetz AS; Robson S; Lau D; Block TM; Moss AC Inflamm Bowel Dis; 2013 Dec; 19(13):2796-800. PubMed ID: 24185312 [TBL] [Abstract][Full Text] [Related]
3. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease. Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574 [TBL] [Abstract][Full Text] [Related]
5. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities. Philipsen EK; Bondesen S; Andersen J; Larsen S Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250 [TBL] [Abstract][Full Text] [Related]
6. A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum. Filley E; Andreoli A; Steele J; Waters M; Wagner D; Nelson D; Tung K; Rademacher T; Dwek R; Rook GA Clin Exp Immunol; 1989 Jun; 76(3):343-7. PubMed ID: 2787714 [TBL] [Abstract][Full Text] [Related]
7. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Minami T; Tojo H; Shinomura Y; Tarui S; Okamoto M Gut; 1992 Jul; 33(7):914-21. PubMed ID: 1644331 [TBL] [Abstract][Full Text] [Related]
8. Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease. MacDermott RP; Nash GS; Auer IO; Shlien R; Lewis BS; Madassery J; Nahm MH Gastroenterology; 1989 Mar; 96(3):764-8. PubMed ID: 2914639 [TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects. Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596 [TBL] [Abstract][Full Text] [Related]
10. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease. Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease. Aldebert D; Masy E; Reumaux D; Lion G; Colombel JF; Duthilleul P Dig Dis Sci; 1997 Nov; 42(11):2350-5. PubMed ID: 9398816 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Giaffer MH; Clark A; Holdsworth CD Gut; 1992 Aug; 33(8):1071-5. PubMed ID: 1398231 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Niederau C; Backmerhoff F; Schumacher B; Niederau C Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Fagan EA; Dyck RF; Maton PN; Hodgson HJ; Chadwick VS; Petrie A; Pepys MB Eur J Clin Invest; 1982 Aug; 12(4):351-9. PubMed ID: 6814926 [TBL] [Abstract][Full Text] [Related]
15. Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease. Shinzaki S; Kuroki E; Iijima H; Tatsunaka N; Ishii M; Fujii H; Kamada Y; Kobayashi T; Shibukawa N; Inoue T; Tsujii M; Takeishi S; Mizushima T; Ogata A; Naka T; Plevy SE; Takehara T; Miyoshi E Inflamm Bowel Dis; 2013 Feb; 19(2):321-31. PubMed ID: 23287897 [TBL] [Abstract][Full Text] [Related]